Sign Up to like & get
recommendations!
0
Published in 2022 at "Journal of Oncology Pharmacy Practice"
DOI: 10.1177/10781552211073673
Abstract: Objective Everolimus is an inhibitor of serine/ threonine kinase mTOR. The drug is approved for the treatment of metastatic ER positive, HER2 negative breast cancers and benefits a subset of patients with these breast cancers…
read more here.
Keywords:
breast cancer;
breast;
efficacy breast;
everolimus efficacy ... See more keywords
Sign Up to like & get
recommendations!
1
Published in 2022 at "Saudi medical journal"
DOI: 10.15537/smj.2022.43.4.20210823
Abstract: the early stages of BC through screening, especially in the high-risk population. We suggest transforming the
read more here.
Keywords:
screening program;
program kingdom;
breast cancer;
kingdom saudi ... See more keywords